Initially, these factors facilitate the proliferation of Th17 cells mediated by tumor cells and tumor-associated fibroblasts and subsequently enhance the recruitment of Th17 cells by upregulating MCP-1 and regulated upon activation normal T cell expressed and secreted factor (RANTES) levels. The gene discussed is CCL2; the disease is neoplasm.